TAF15

TATA-box binding protein associated factor 15, the group of Zinc fingers RANBP2-type |RNA binding motif containing

Basic information

Region (hg38): 17:35809481-35864615

Previous symbols: [ "TAF2N" ]

Links

ENSG00000270647 ∙ NCBI:8148 ∙ OMIM:601574 ∙ HGNC:11547 ∙ Uniprot:Q92804 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

• amyotrophic lateral sclerosis (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TAF15 gene.

• not provided (84 variants)
• Inborn genetic diseases (21 variants)
• TAF15-related condition (13 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAF15 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous				10	10	20
missense			37	3	2	42
nonsense						0
start loss						0
frameshift						0
inframe indel			6	4	5	15
splice donor/acceptor (+/-2bp)						0
splice region				1		1
non coding				15	19	34
Total	0	0	43	32	36

Variants in TAF15

This is a list of pathogenic ClinVar variants found in the TAF15 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
17-35809864-G-A			Likely benign (Aug 17, 2018)
17-35817456-A-G			Benign (Apr 24, 2019)
17-35817514-A-G			Likely benign (Jun 19, 2019)
17-35817699-C-A			Likely benign (Dec 24, 2019)
17-35819814-C-A			Benign (Aug 10, 2018)
17-35820186-C-T		not specified	Uncertain significance (Oct 05, 2021)
17-35820187-G-A		TAF15-related disorder	Likely benign (Jul 26, 2021)
17-35820207-A-G			Uncertain significance (Jan 21, 2022)
17-35820218-G-A		TAF15-related disorder	Likely benign (Jun 30, 2022)
17-35820316-C-T			Likely benign (Nov 05, 2020)
17-35820352-G-T		TAF15-related disorder	Likely benign (Apr 21, 2023)
17-35820370-C-G			Uncertain significance (Jan 02, 2020)
17-35820374-G-T			Uncertain significance (Feb 26, 2023)
17-35820395-A-G		not specified	Uncertain significance (Feb 07, 2023)
17-35820529-CT-C			Benign (Nov 02, 2019)
17-35820543-A-T			Likely benign (Sep 22, 2019)
17-35820594-G-A			Likely benign (Aug 10, 2018)
17-35822344-CA-C			Likely benign (Aug 21, 2019)
17-35822344-C-CA			Benign (Aug 26, 2019)
17-35822498-A-G			Benign (Jul 03, 2018)
17-35822556-G-A			Benign (Sep 29, 2018)
17-35822663-A-G		not specified	Uncertain significance (Aug 17, 2022)
17-35822678-A-G		TAF15-related disorder	Uncertain significance (Nov 13, 2023)
17-35822714-A-G		TAF15-related disorder	Likely benign (Nov 14, 2019)
17-35822738-A-C		not specified	Uncertain significance (Mar 17, 2023)

GnomAD

Source: gnomAD

dbNSFP

Source: dbNSFP

• Function: FUNCTION: RNA and ssDNA-binding protein that may play specific roles during transcription initiation at distinct promoters. Can enter the preinitiation complex together with the RNA polymerase II (Pol II). {ECO:0000269|PubMed:19124016}.
• Disease: DISEASE: Note=A chromosomal aberration involving TAF15/TAF2N is found in a form of extraskeletal myxoid chondrosarcomas (EMC). Translocation t(9;17)(q22;q11) with NR4A3. {ECO:0000269|PubMed:10602519}.
• Pathway: Basal transcription factors - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Disease;Gene expression (Transcription);Generic Transcription Pathway;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;HIV Transcription Initiation;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53 (Consensus)

Recessive Scores

• pRec: 0.0959

Intolerance Scores

• loftool: 0.211
• rvis_EVS: -0.78
• rvis_percentile_EVS: 12.97

Haploinsufficiency Scores

• pHI: 0.428
• hipred: N
• hipred_score: 0.444

Essentials

• essential_gene_CRISPR: E
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: H
• gene_indispensability_pred: E
• gene_indispensability_score: 0.618

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Taf15

Gene ontology

• Biological process: transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;positive regulation of transcription, DNA-templated;regulation of signal transduction by p53 class mediator
• Cellular component: nucleus;nucleoplasm;nucleolus;cytoplasm
• Molecular function: DNA binding;RNA binding;protein binding;metal ion binding